Literature DB >> 8906990

Long polymerase chain reaction amplification of heterogeneous HIV type 1 templates produces recombination at a relatively high frequency.

Y L Yang1, G Wang, K Dorman, A H Kaplan.   

Abstract

Studies of HIV molecular evolution and pathogenesis have relied on the polymerase chain reaction (PCR) to provide sequence information from infected tissues. Until recently, studies have been constrained by the limited length of fragments that can be reliably amplified. The addition of a thermostable 3'-exonuclease activity and altered cycling profiles has increased the length of target sequences that can be amplified by more than 10-fold. We have evaluated the fidelity of long PCR (LPCR). We determined that LPCR amplification maintains the distribution of sequences found in a heterogeneous sample and introduces nucleotide misincorporations at a rate comparable to that found with routine PCR. However, a significant proportion of the LPCR-amplified DNA fragments resulted from recombination events. This result suggests that LPCR amplification may have limited utility in the production and analysis of full-length HIV clones.

Mesh:

Year:  1996        PMID: 8906990     DOI: 10.1089/aid.1996.12.303

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

1.  Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.

Authors:  Cassandra B Jabara; Corbin D Jones; Jeffrey Roach; Jeffrey A Anderson; Ronald Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-30       Impact factor: 11.205

2.  Stimulation and suppression of PCR-mediated recombination.

Authors:  M S Judo; A B Wedel; C Wilson
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

3.  Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR.

Authors:  M T Dittmar; G Simmons; Y Donaldson; P Simmonds; P R Clapham; T F Schulz; R A Weiss
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple.

Authors:  M O Salminen; J K Carr; D L Robertson; P Hegerich; D Gotte; C Koch; E Sanders-Buell; F Gao; P M Sharp; B H Hahn; D S Burke; F E McCutchan
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  The efficiency of single genome amplification and sequencing is improved by quantitation and use of a bioinformatics tool.

Authors:  David M Butler; Mary E Pacold; Parris S Jordan; Douglas D Richman; Davey M Smith
Journal:  J Virol Methods       Date:  2009-08-19       Impact factor: 2.014

6.  Pervasive genomic recombination of HIV-1 in vivo.

Authors:  Daniel Shriner; Allen G Rodrigo; David C Nickle; James I Mullins
Journal:  Genetics       Date:  2004-08       Impact factor: 4.562

7.  In vitro direct repeats-mediated deletion during PCR amplification.

Authors:  Basma Hadj Kacem; Jalel Gargouri; Ali Gargouri
Journal:  Mol Biotechnol       Date:  2008-03-26       Impact factor: 2.695

8.  Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing.

Authors:  Jesus F Salazar-Gonzalez; Elizabeth Bailes; Kimmy T Pham; Maria G Salazar; M Brad Guffey; Brandon F Keele; Cynthia A Derdeyn; Paul Farmer; Eric Hunter; Susan Allen; Olivier Manigart; Joseph Mulenga; Jeffrey A Anderson; Ronald Swanstrom; Barton F Haynes; Gayathri S Athreya; Bette T M Korber; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

9.  Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations.

Authors:  Mark A Winters; Robert M Lloyd; Robert W Shafer; Michael J Kozal; Michael D Miller; Mark Holodniy
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

10.  Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.

Authors:  Teresa H Evering; Saurabh Mehandru; Paul Racz; Klara Tenner-Racz; Michael A Poles; Amir Figueroa; Hiroshi Mohri; Martin Markowitz
Journal:  PLoS Pathog       Date:  2012-02-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.